Abstract
To evaluate the endometrial hyperplasia and carcinoma rate after 52-week treatment with ultra-low-dose 10-microgram 17β-estradiol vaginal tablets in postmenopausal women with vaginal atrophy.
| Original language | English |
|---|---|
| Journal | Key Obstetrics and Gynecology |
| Volume | 116 |
| Issue number | 4 |
| Pages (from-to) | 876-83 |
| Number of pages | 8 |
| ISSN | 0896-4467 |
| DOIs | |
| Publication status | Published - 1 Oct 2010 |
Fingerprint
Dive into the research topics of 'Endometrial safety of ultra-low-dose estradiol vaginal tablets'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS